2-(phenyl or heterocyclic)-1H-phenantrho[9,10-d]imidazoles as mPGES-1 inhibitors

Details for Australian Patent Application No. 2006317419 (hide)

Owner Merck Frosst Canada Ltd.

Inventors Ducharme, Yves; Martins, Evelyn; Friesen, Richard; Giroux, Andre; Chau, Anh; Yu, Hongping; Gagnon, Marc; Wu, Tom; Frenette, Richard; Cote, Bernard

Agent Spruson & Ferguson

Pub. Number AU-A-2006317419

PCT Pub. Number WO2007/059610

Priority 11/374,288 23.11.05 US

Filing date 21 November 2006

Wipo publication date 31 May 2007

International Classifications

C07D 235/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4184 (2006.01)

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

5 June 2008 PCT application entered the National Phase

  PCT publication WO2007/059610 Priority application(s): WO2007/059610

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006317424-Method and system of computer-aided quantitative and qualitative analysis of medical images

2006317350-Methods and proteins for the prophylactic and/or therapeutic treatment of the four serotypes of dengue virus and other flaviviruses